Vimarsana
Biggest News Aggregation in the World

Page 2 - Prior Plan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Prior Plan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Prior Plan Today - Breaking & Trending Today

Travere Therapeutics : Equity Incentive Plan - Form 8-K - Vimarsana News

Travere Therapeutics : Equity Incentive Plan - Form 8-K

2018 Equity Incentive Plan Adopted by the Board of Directors: April 1, 2018 Approved by the Stockholders: May 9, 2018 Amended by the Board of... | May 23, 2023

PAYSIGN, INC. : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K) - Vimarsana News

PAYSIGN, INC. : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On May 5, 2023, we held our annual... | May 9, 2023

America First Multifamily Investors, L.P. Announces Name Change to Greystone Housing Impact Investors LP and Listing on the New York Stock Exchange - Vimarsana News

America First Multifamily Investors, L.P. Announces Name Change to Greystone Housing Impact Investors LP and Listing on the New York Stock Exchange

OMAHA, Neb., Dec. 05, 2022 -- America First Multifamily Investors, L.P. announced that, effective 12:01 a.m. Eastern Time on December 5, 2022, it has changed its legal name to Greystone Housing... | December 5, 2022

Tryp Therapeutics Inc.: Tryp Therapeutics to Present at the H.C. Wainwright Psychedelics Conference - Vimarsana News

Tryp Therapeutics Inc.: Tryp Therapeutics to Present at the H.C. Wainwright Psychedelics Conference

San Diego, California--(Newsfile Corp. - June 1, 2021) - Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) (FSE: 8FW) ("Tryp"), a pharmaceutical company focused on developing compounds for diseases with unmet